Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Krack Cream is a topical Ayurvedic antiseptic formulation designed to treat dry, rough, and cracked heels, chapped hands, fissures, and chilblains. Originally launched in 1993 by Paras Pharmaceuticals, the brand was acquired by Reckitt Benckiser in 2010, and subsequently sold to Yellow Wood Partners (Scholl Wellness Company) in 2021. In 2022, Brinton Pharmaceuticals partnered with Scholl Wellness Company to handle the sales, marketing, and distribution of Krack Cream in India. The cream is enriched with a blend of traditional Ayurvedic herbs and oils, including Daruharidra, Kampillaka, Pashanabheda, Manjishtha, Payasvini, and Tila Taila (sesame oil), which work synergistically to deeply moisturize, soothe, and repair damaged skin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Krack Cream.